JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takemori, A. E.
Right arrow Articles by Stenwick, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takemori, A. E.
Right arrow Articles by Stenwick, M. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 3, 586-594, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE UPTAKE OF MORPHINE BY THE CHOROID PLEXUS IN VITRO

A. E. Takemori 1 and Michael W. Stenwick 1

1 Department of Pharmacology, University of Minnesota, College of Medical Sciences, Minneapolis, Minnesota

When choroid plexuses from rabbits are incubated aerobically at 37°C with morphine, the tissue takes up morphine by a process which satisfies the usual criteria for active transport. Morphine is taken up against an apparent concentration gradient and high concentrations of morphine can saturate the transport system. The uptake of morphine can be inhibited by low temperature, metabolic inhibitors and compounds with similar structures, such as codeine and levallorphan. Morphine is transported much more readily at alkaline pH and the transport process is dependent on the presence of Ca++ and Mg++ ions. Morphine is released exponentially from the choroid plexus at an initial fast rate and a secondary slow rate. Only the slower rate is influenced by metabolic inhibitors or levallorphan. Since hexamethonium does not inhibit the uptake of morphine, the active transport system in the choroid plexus for quaternary amines appears to differ from that for morphine, a tertiary amine. Other differences between the two systems are discussed. The implication of this choroidal uptake system in the transport of morphine into or out of the cerebrospinal fluid is also discussed.

Submitted on March 21, 1966
Accepted on June 3, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.